These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Merck's recall of rofecoxib--a strategic perspective. Oberholzer-Gee F; Inamdar SN N Engl J Med; 2004 Nov; 351(21):2147-9. PubMed ID: 15548771 [No Abstract] [Full Text] [Related]
27. Turning over a new leaf versus shaking the tree. Stewart-Amidei C J Neurosci Nurs; 2004 Oct; 36(5):243. PubMed ID: 15524238 [No Abstract] [Full Text] [Related]
28. The problem of new uses. Eisenberg RS Yale J Health Policy Law Ethics; 2005; 5(2):717-39. PubMed ID: 16052897 [No Abstract] [Full Text] [Related]
29. Innovative strategies for early clinical R&D. Butz RF; Morelli G IDrugs; 2008 Jan; 11(1):36-41. PubMed ID: 18175261 [TBL] [Abstract][Full Text] [Related]
30. FDA signals it's open to drug trials that shift midcourse. Mathews AW Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817 [No Abstract] [Full Text] [Related]
31. Is the drought over for pharming? Kaiser J Science; 2008 Apr; 320(5875):473-5. PubMed ID: 18436771 [No Abstract] [Full Text] [Related]
33. Branded drug reformulation: the next brand vs. generic antitrust battleground. Amoresano GV Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032 [No Abstract] [Full Text] [Related]
34. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency. Schultheis LW; Rappaport BA Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189 [No Abstract] [Full Text] [Related]
35. The market for follow-on biologics: how will it evolve? Grabowski H; Cockburn I; Long G Health Aff (Millwood); 2006; 25(5):1291-301. PubMed ID: 16966725 [TBL] [Abstract][Full Text] [Related]
36. Drug marketing exclusivity under United States and European Union law. Junod V Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347 [No Abstract] [Full Text] [Related]
39. This Dutchman is flying. Watson N Fortune; 2003 Jun; 147(13):89-90. PubMed ID: 12827720 [No Abstract] [Full Text] [Related]
40. Steve Carney talks to Vincent Lee on the pharma industry, the FDA and public education with respect to drugs and their development. Lee VH Drug Discov Today; 2005 Nov; 10(21):1411-4. PubMed ID: 16243258 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]